HOME ·

biopharmaceutical

HENGRUI PHARMA (01276.HK): Class 1 Innovative Drug Ivarmacitinib Sulfate Tablets Approved for Fifth Indication, Completing Full-Disease-Spectrum Coverage of Axial Spondyloarthritis
Tags：
HENGRUI PHARMA01276.HKbiopharmaceutical
2026-08-06
CARsgen Therapeutics (02171.HK) CT041 Postoperative Adjuvant Therapy Study Results Accepted for ESMO 2026 Poster Presentation
Tags：
CARSGEN-B02171.HKbiopharmaceutical
2026-07-15
Insilico Medicine Launches Hong Kong's Largest Biopharma IPO of the Year with HKIC as Strategic Investor
Tags：
InsilicoHKICIPObiopharmaceutical
2025-12-31